Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
  • Past Issues

Neutropenia as a side effect of prescrebing risperidone on adolescent with autism

Breadcrumb

  • Home
  • Neutropenia as a side effect of prescrebing risperidone on adolescent with autism

Bouchra Aabbassi 1, * and Abdeslam Benali 2

1 Child and adolescent psychiatrist, Psychiatric Hospital Ibn Nafis, Marrakesh, Morocco.
2 Research team for mental health, University Cadi Ayyad, Marrakesh, Morocco.

Case Study
 

World Journal of Advanced Research and Reviews, 2022, 13(03), 360–362
Article DOI: 10.30574/wjarr.2022.13.3.0246
DOI url: https://doi.org/10.30574/wjarr.2022.13.3.0246

Received on 02 February 2022; revised on 19 March 2022; accepted on 21 March 2022

Neutropenia is an adverse effect of various pharmacological therapies, including antipsychotics. However, risperidone tends to have a lower risk of hematotoxicity. We report a case of a 14 years old boy with a diagnosis of autism who developed neutropenia after administration of risperidone and was able to resolved it after discontinuation. This is a rare case report of risperidone-induced neutropenia on adolescent.

Risperidone; Antipsychotics; Neutropenia; Blood dyscrasias; Adolescent

https://wjarr.co.in/sites/default/files/fulltext_pdf/WJARR-2022-0246.pdf

Preview Article PDF

Bouchra Aabbassi and Abdeslam Benali. Neutropenia as a side effect of prescrebing risperidone on adolescent with autism. World Journal of Advanced Research and Reviews, 2022, 13(03), 360–362. Article DOI: https://doi.org/10.30574/wjarr.2022.13.3.0246

Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0

Footer menu

  • Contact

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution